Skip to main content
Log in

Correlation between melatonin concentration and cytokines in cervical mucus in positive samples for the presence of human papillomavirus

  • Research Report
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Abstract

The human papillomavirus (HPV) is the main causative agent of cervical cancer, characterized by neoplastic lesions in the cervix. Based on the morphology of the cells of the uterine cervix, the findings are classified as negative intraepithelial lesions for malignancies, low-grade squamous intraepithelial lesions, high-grade squamous intraepithelial lesions (HSILs), atypical squamous cells of undetermined significance and atypical squamous cells of undetermined significance without excluding HSILs (ASCs-H). The progression of neoplastic lesions is related to the cervix's microenvironmental inflammatory process and mediated by the expression and stimulation of cytokines. Cervical mucus is a viscous liquid secretion composed of proteins, inorganic components, pro-and anti-inflammatory agents, and an important protective barrier. This study aimed to quantify and correlate cytokines IL-6, IL-8, and IL-10 and Melatonin in cervical mucus. According to the results, a decrease in MLT was observed in LSIL, HSI, and ASC-H groups than in the NILM group. The cytokines IL-6 and IL-8 showed greater expression in the LSIL and HSIL groups than the NILM group. HSIL group showed a negative correlation between the MLT and IL-6 and IL-8 concentrations. In the ASC-US group, IL8 level was positively correlated to MLT levels. We suggest that IL-6, IL-8, and MLT levels in HSIL groups are decisive for the progression of neoplastic lesions in HPV infections. New cervical cancer treatment strategies may include cytokine and melatonin control targets for effective immunotherapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Data availability

The original data are shown in Figs. 1, 2 and 3, and Table 1 used to support this study's findings are available from the corresponding author upon request.

References

  1. Munoz N, Castellsagué X, González AB, Gissmann L (2006) HPV in the etiology of human cancer. Vaccine 24:S1–S10. https://doi.org/10.1016/j.vaccine.2006.05.115

    Article  CAS  Google Scholar 

  2. Alves DB, Tozetti IA, Gatto FA, Cassandri F, Ferreira AMT, Ferreira CES, Abdo MAGS (2010) Linfócitos CD4, CD8 e células NK no estroma da cérvice uterina de mulheres infectadas pelo papilomavírus humano. Rev Soc Bras Med Trop 43:425–429. https://doi.org/10.1590/S0037-86822010000400018

    Article  PubMed  Google Scholar 

  3. Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, Bray F (2020) Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 8:e191–e203. https://doi.org/10.1016/S2214-109X(19)30482-6

    Article  PubMed  Google Scholar 

  4. The 1988 Bethesda System for reporting cervical/vaginal cytologic diagnoses (1989) Diagn Cytopathol. 5:331–334. https://doi.org/https://doi.org/10.1002/dc.2840050318

  5. Prata TTM, Bonin CM, Ferreira AMT, Padovani CTJ, Fernandes CEDS, Machado AP, Tozetti IA (2015) Local immunosuppression induced by high viral load of human papillomavirus: characterization of cellular phenotypes producing interleukin-10 in cervical neoplastic lesions. Immunol 146:113–121. https://doi.org/10.1111/imm.12487

    Article  CAS  Google Scholar 

  6. Marques JPH, Costa LB, Pinto APS, Barbosa ACF, Medeiros PL (2011) Atypical glandular cells and cervical cancer: systematic review. Rev Assoc Med Bras 57:234–238

    Article  Google Scholar 

  7. Li B, Zhang L, Zhao J, Tan G, Zhang W, Zhang N, Tian J, Qu P (2019) The value of cytokine levels in triage and risk prediction for women with persistent high-risk human papilloma virus infection of the cervix. Infect Agents Cancer 16:1–12. https://doi.org/10.1186/s13027-019-0231-z

    Article  CAS  Google Scholar 

  8. Tjiong MY, van der Vange N, ten Kate FJ, Tjong-A-Hung SP, Schegget J, Burger MP, Out TA (1999) Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer. Gynecol Oncol 73:284–291. https://doi.org/10.1006/gyno.1999.5358

    Article  Google Scholar 

  9. Pandi-Perumal SR, Srinivasan V, Maestroni GJM, Cardinali DP, Poeggeler B, Hardeland R (2006) Melatonin: nature’s most versatile biological signal? FEBS J 273:2813–2838. https://doi.org/10.1111/j.1742-4658.2006.05322.x

    Article  CAS  PubMed  Google Scholar 

  10. Vijayalaxmi TJ, CR, Reiter RJ, Herman TS (2002) Melatonin: from basic research to cancer treatment clinics. J. clin. Oncol 20: 2575-2601. https://doi.org/https://doi.org/10.1200/JCO.2002.11.004

  11. Martínez-Campa C, Gonzalez A, Mediavilla MD, Alonso-Gonzalez C, Sanchez-Barcelo EJ, Cos S (2005) Melatonin enhances the inhibitory effect of aminoglutethimide on aromatase activity in MCF-7 human breast cancer cells. Breast Cancer Res Treat 94:249–254. https://doi.org/10.1007/s10549-005-9006-x

    Article  CAS  PubMed  Google Scholar 

  12. Cotrim ACM, França EL, Honório-França AC, Martins JS, Silva KPG, Ghalfi YC, Machado IT, Tozetti IA (2020) Effect of polyethylene glycol microspheres adsorbed with melatonin on oxidative stress and viscosity of cervical mucus samples infected with human papillomavirus. BRIAC 10:6757–6772

    CAS  Google Scholar 

  13. Masana MI, JrJM S, Dubocovich ML (2005) 17β-estradiol modulates hMT1 melatonin receptor function. Neuroendocrinol 81:87–95. https://doi.org/10.1159/000084897

    Article  CAS  Google Scholar 

  14. Rönnberg L, Kauppila A, Leppäluoto J, Martikainen H, Vakkuri O (1990) Circadian and seasonal variation in human preovulatory follicular fluid melatonin concentration. J Clin Endocrinol Metab 71:493–496. https://doi.org/10.1210/jcem-71-2-493

    Article  Google Scholar 

  15. Romero MB, Ocejo LO (2000) Angiogenesis modulators expression in culture cell lines positives for HPV-16 oncoproteins. Biochem Biophys Res Commun 277:55–61. https://doi.org/10.1006/bbrc.2000.3628

    Article  CAS  Google Scholar 

  16. Shiau MY, Fan LC, Yang SC, Tsao CH, Lee H, Cheng YW, Lai LC, Chang YH (2013) Human papillomavirus Up-regulates MMP-2 and MMP-9 expression and activity by inducing Interleukin-8 in lung adenocarcinomas. PLoS ONE 8:1–8. https://doi.org/10.1371/journal.pone.0054423

    Article  CAS  Google Scholar 

  17. Zhang E, Feng X, Liu F, Zhang P, Liang J, Tang X (2014) Roles of PI3K/Akt and c-Jun signaling pathways in human papillomavirus type 16 oncoprotein-induced HIF-1α, VEGF, and IL-8 expression and in vitro angiogenesis in non-small cell lung cancer cells. Plo One 9:1–13. https://doi.org/10.1371/journal.pone.0103440

    Article  CAS  Google Scholar 

  18. Cutando A, Montero J, Gomez DR, Ferrera MJ, Lopez-Valverde A (2015) Effect of topical application of melatonin on serum levels of C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) in patients with type 1 or type 2 diabetes and periodontal disease. J Clin Exp Dente 7:e638–e633. https://doi.org/10.4317/jced.52604

    Article  Google Scholar 

  19. Xu X, Wang G, Ai L, Shi J, Zhang J, Chen YX (2018) Melatonin suppresses TLR9-triggered proinflammatory cytokine production in macrophages by inhibiting ERK1/2 and AKT activation. Sci Rep 8:1–10. https://doi.org/10.1038/s41598-018-34011-8

    Article  CAS  Google Scholar 

  20. Choi EY, Jin JY, Lee JY, Choi JI, Choi IS, Kim SJ (2011) Melatonin inhibits Prevotella intermedia lipopolysaccharide-induced production of nitric oxide and interleukin-6 in murine macrophages by suppressing NF-κB and STAT1 activity. J Pineal Res 50:197–206. https://doi.org/10.1111/j.1600-079X.2010.00829.x

    Article  CAS  PubMed  Google Scholar 

  21. Zhou W, Zhang X, Zhu CL, He ZY, Liang JP, Song ZC (2016) Melatonin receptor agonists as the “Perioceutics” agents for periodontal disease through modulation of porphyromonas gingivalis virulence and inflammatory response. PLoS ONE 11:1–20. https://doi.org/10.1371/journal.pone.0166442

    Article  CAS  Google Scholar 

Download references

Funding

This study was funded by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior- Brazil (CAPES) funded project code 001. This work was supported by the Conselho Nacional de Desenvolvimento Científico e Tecnológico-CNPq under Grant (number 447218/2014–0 and 305725/2018–1), Brazil.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eduardo Luzia França.

Ethics declarations

Conflicts of interest

All the authors declare no conflict of interest and non-financial competing interests.

Ethics approval

The local Ethics Committee approved this study under the number protocol 2.735.360.

Informed consent

All the volunteers selected to participate provided informed consent before participating in the study, and guidelines have been duly followed.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cotrim, A.C.M., França, E.L., Martins, J.S. et al. Correlation between melatonin concentration and cytokines in cervical mucus in positive samples for the presence of human papillomavirus. Cancer Immunol Immunother 70, 2721–2726 (2021). https://doi.org/10.1007/s00262-021-02922-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00262-021-02922-7

Keywords

Navigation